Form 4 for TAK TAKEDA PHARMACEUTICAL CO LTD
Accepted 2026-07-06 18:11:16 ET · period of report 2026-07-01 · accession 0001395064-26-000266 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-07-06 18:11 | 2026-07-01 | TAK | Stoffels Paulus | Dir | A - Grant | $0.00 | +3,800 | 3,800 | New | $0 |
| D | 2026-07-06 18:11 | 2026-07-01 | TAK | Stoffels Paulus | Dir | A - Grant | $0.00 | +1,307 | 1,307 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-07-01 | A | A | 3,800 | $0.00 | 3,800 | D | — | — | (F1) Represents an award of restricted stock units (RSU). Each RSU represents a contingent right to receive one Ordinary Share, which will be converted into an equivalent number of American Depositary Shares following vest. The RSUs vest on June 1, 2029. |
| 2 | Derivative | Tax Obligation Award | 2026-07-01 | A | A | 1,307 | $0.00 | 1,307 | D | — · 2029-06-01 to 2029-06-01 | 1,307 Ordinary Shares | (F2) Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares. |